Literature DB >> 12673251

PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression.

Yuxin Yin1, Yu-Xin Liu, Yan J Jin, Eric J Hall, J Carl Barrett.   

Abstract

p53 has a role in many cellular processes through the transcriptional regulation of target genes. PAC1 (phosphatase of activated cells 1; also known as dual specificity phosphatase 2, DUSP2) is a dual threonine/tyrosine phosphatase that specifically dephosphorylates and inactivates mitogen-activated protein (MAP) kinases. Here we show that during apoptosis, p53 activates transcription of PAC1 by binding to a palindromic site in the PAC1 promoter. PAC1 transcription is induced in response to serum deprivation and oxidative stress, which results in p53-dependent apoptosis, but not in response to gamma-irradiation, which causes cell cycle arrest. Reduction of PAC1 transcription using small interfering RNA inhibits p53-mediated apoptosis, whereas overexpression of PAC1 increases susceptibility to apoptosis and suppresses tumour formation. Moreover, activation of p53 significantly inhibits MAP kinase activity. We conclude that, under specific stress conditions, p53 regulates transcription of PAC1 through a new p53-binding site, and that PAC1 is necessary and sufficient for p53-mediated apoptosis. Identification of a palindromic motif as a p53-binding site may reveal a novel mechanism whereby p53 regulates its target genes.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12673251     DOI: 10.1038/nature01519

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  43 in total

1.  Gallium compound GaQ(3) -induced Ca(2+) signalling triggers p53-dependent and -independent apoptosis in cancer cells.

Authors:  Rajan Gogna; Esha Madan; Bernhard Keppler; Uttam Pati
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.

Authors:  Jamie M Hearnes; Deborah J Mays; Kristy L Schavolt; Luojia Tang; Xin Jiang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

3.  Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells.

Authors:  Shih-Chieh Lin; Chun-Wei Chien; Jenq-Chang Lee; Yi-Chun Yeh; Keng-Fu Hsu; Yen-Yu Lai; Shao-Chieh Lin; Shaw-Jenq Tsai
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

4.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

5.  p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.

Authors:  Hong-Chuan Zhao; Qi Zhang; Yang Yang; Min-Qiang Lu; Hua Li; Chi Xu; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

6.  Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma.

Authors:  Yusuf Ziya Igci; Ahmet Arslan; Ersin Akarsu; Suna Erkilic; Mehri Igci; Serdar Oztuzcu; Beyhan Cengiz; Bulent Gogebakan; Ecir Ali Cakmak; A Tuncay Demiryurek
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

7.  Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state.

Authors:  Andrea Schietinger; Jeffrey J Delrow; Ryan S Basom; Joseph N Blattman; Philip D Greenberg
Journal:  Science       Date:  2012-01-19       Impact factor: 47.728

Review 8.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

9.  Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.

Authors:  Matteo Rossi; Oleg N Demidov; Carl W Anderson; Ettore Appella; Sharlyn J Mazur
Journal:  Nucleic Acids Res       Date:  2008-11-10       Impact factor: 16.971

10.  Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.

Authors:  Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.